Jasbir Seehra, CEO of Keros Therapeutics ($KROS), sold shares once on the open market in the last 365 days for a total of $113,432. His most recent sale occurred on February 19, 2026. These sales rank 9,385th among 11,678 individual insiders, where the average sale totals about $8.6 million across roughly 6.4 transactions. Seehra made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 41,202,371 | 9999.99% | 0.24% |
| Feb. 24, 2026 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (Right to Buy) | 217000 | $0.00 | 217,000.0000 | 41,202,371 | 9999.99% | 0.53% |
| Feb. 19, 2026 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7015 | $16.17 | 385,708.0000 | 41,202,371 | 1.79% | 0.02% |
| Jan. 7, 2026 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 62500 | $0.00 | 62,500.0000 | 41,202,371 | 9999.99% | 0.15% |
| Sept. 3, 2025 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | A | Common Stock | 90500 | $0.00 | 392,723.0000 | 37,437,652 | 29.94% | 0.24% |
| April 4, 2025 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | M | Common Stock | 49367 | $0.30 | 302,223.0000 | 37,437,652 | 19.52% | 0.13% |
| April 4, 2025 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | M | Employee Stock Option (right to buy) | 49367 | $0.00 | 252,444.0000 | 37,437,652 | 16.36% | 0.13% |
| Feb. 23, 2024 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 29,447,119 | 9999.99% | 0.42% |
| Feb. 13, 2024 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 29,447,119 | 9999.99% | 0.42% |
| April 8, 2023 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | Chief Executive Officer | M | Employee Stock Option (right to buy) | 4000 | $0.00 | 45,087.0000 | 25,241,030 | 8.15% | 0.02% |
| April 8, 2023 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | Chief Executive Officer | M | Common Stock | 4000 | $0.48 | 252,856.0000 | 25,241,030 | 1.61% | 0.02% |
| Feb. 16, 2023 | Keros Therapeutics, Inc. | $KROS | Seehra Jasbir | Chief Executive Officer | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 25,241,030 | 9999.99% | 0.79% |